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Background 
There are more than 310 million surgical procedures worldwide each year.1 In the UK, one in ten adults 
has a surgical procedure each year, and the annual number of procedures is increasing steadily.2 
Estimates of post-operative morbidity and mortality vary, but approximately seven million patients 
worldwide experience a post-operative complication each year.3-5 Post-operative infections increase 
morbidity and mortality, and prolong intensive care and hospital stays.6 
 
Post-operative infections are an important cause of post-operative death, although estimates vary 
widely. For example, organ space infection has reported mortality rates between 4 and 9%, and 
mortality ranges from 28 to 46% in those patients who progress to septic shock.7 8 Many post-
operative infections do not progress to severe sepsis or septic shock and the mode of death for such 
patients is unclear. Previously reported rates of mortality for different types of infection vary widely 
depending on the population. The literature remains unclear about the overall rates of post-operative 
infection and subsequent outcomes. The relationships between different types of infection, surgical 
procedures, and other adverse outcomes are also unclear. 
 
There are few large epidemiological studies which explore the risk factors and outcomes of post-
operative infection. Increasing knowledge and ability to provide accurate and generalisable estimates 
of the key risk factors for infection and subsequent patient outcomes will aid prevention of serious 
post-operative infections, particularly on a global level 
 
The International Surgical Outcomes Study aimed to provide a detailed description of post-operative 
complications across a large international cohort.9 The aim of this secondary analysis is to describe 
the prevalence of post-operative infection in an international sample of surgical patients. We will also 
investigate risk factors for the development of infection and the association between infection and 
morbidity and mortality following elective surgery. 
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Aim 
To describe the incidence and types of post-operative infection which occur following elective surgery; 
baseline risk factors for its development; and its association with adverse clinical outcomes within 30 
days (specific endpoints defined below). 
 
Objectives 
1. To describe the incidence, type, and severity of post-operative infection 
2. To identify baseline risk factors for the development of post-operative infection: 
- patient characteristics 
- anaesthetic and surgical factors 
3. To determine 30-day mortality for patients who do and do not develop different types of post-
operative infection 
4. To determine if post-operative infection influences process measures 
- critical care length of stay 
- hospital length of stay 
 
Data collection 
Study cohort 
The International Surgical Outcome Study (ISOS) is an international multi-centre cohort study of 
perioperative morbidity and mortality in patients undergoing elective surgery (ISRCTN51817007).9 
Data collection occurred during a seven-day period between April and August 2014 in 474 hospitals in 
27 countries. All patients admitted to participating centres for elective surgery with a planned 
overnight stay were eligible. Patients undergoing day-case surgery or radiological procedures were 
excluded because they followed a dedicated pathway of care. The total sample size collected is 44,863. 
Patients were followed up for a maximum of 30 days after surgery. 
 
Sample 
The dataset for this secondary analysis includes only patients from the ISOS cohort with mortality 
outcome data resulting in a sample size of 44,814. 
 
Key variables 
The paper case report form (CRF) in shown in appendix 1. Independent variables which will be included 
in analyses for patient characteristics and anaesthetic and surgical factors are listed in table (i). The 
outcome variable infection is a composite measure of six different types of infection where more than 
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one type can occur in the same patient: superficial surgical site, deep surgical site, body cavity, 
pneumonia, urinary tract, and bloodstream. Each type is graded by severity 
(mild/moderate/severe/none). Additional outcomes measures will include mortality, critical care 
length of stay and hospital length of stay. 
 
Three variables are listed for treatment for post-operative complications: 
Drug therapy, blood transfusion or parenteral nutrition (Y/N) 
Surgical or radiological procedure (Y/N) 
Critical care admission (Y/N) 
We will only look at this variable in the subset of patients who did not have any other complications 
not related to infection: cardiovascular or other complications. This is to ensure that any variable 
selected for treatment for post-operative complications is due to treatment for an infective 
complication. 
5 
 
Version 1.1 22/02/19 
Table (i). List of key independent variables. 
Variable Type of data Note 
Patient characteristics 
Age in years Continuous  
Sex (M/F) Binary  
Current smoker (Y/N) Binary  
ASA (I-IV) Categorical  
Coronary artery disease (Y/N) Binary 
Chronic disease diagnosis 
Diabetes mellitus (Y/N) Binary 
Metastatic cancer (Y/N) Binary 
COPD/asthma (Y/N) Binary 
Heart failure (Y/N) Binary 
Cirrhosis (Y/N) Binary 
Stroke (Y/N) Binary 
Other (Y/N) Binary 
Haemoglobin g/L Continuous 
Most recent blood result Sodium mmol/L Continuous Leukocytes x109/L Continuous 
Creatinine µmol/L Continuous 
Anaesthetic and surgical factors 
General anaesthetic Binary 
Anaesthetic technique Spinal Binary Epidural Binary 
Sedation/local Binary 
Surgical procedure (Orthopaedic/Breast/Obstetrics and gynaecology/Urology and kidney/Upper 
gastro-intestinal/Lower gastro-intestinal/Hepato-biliary/Vascular/Head and neck/Plastics and 
cutaneous/Cardiac/Thoracic/Other) 
Categorical  
Severity of surgery (Minor/Intermediate/Major) Categorical  
Laparoscopic surgery (Y/N) Binary  
Cancer surgery (Y/N) Binary  
Surgical checklist used (Y/N) Binary  
Critical care immediately after surgery (Y/N) Binary  
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Statistical analysis 
Baseline characteristics for patients who experienced no infection compared to infection will be 
summarised but not subjected to statistical testing. Numbers (%), means (SD) and medians (IQR) will 
be provided separately for each group. Incidence of infection will be presented by type and severity.  
 
The primary outcome will be the development of post-operative infection within 30 days following 
surgery.  The primary outcome will be defined as being recorded if data are available for each of the 
following components:  
• Superficial surgical site  
• Deep surgical site  
• Body cavity  
• Pneumonia 
• Urinary tract  
• Bloodstream  
The primary outcome is defined as missing if data are missing for the above six components. Cases 
missing outcome data for post-operative infection will be excluded from the analysis (Figure 1).  
 
The primary outcome will be analysed using a mixed effects logistic regression model, with a random 
intercept for country and site. The model will be adjusted for the following pre-specified baseline 
covariates: age, gender, coronary artery disease, heart failure, diabetes mellitus, cirrhosis, metastatic 
cancer, stroke, COPD/asthma, other co-morbid diseases, ASA score (I & II vs. III & IV), surgical 
procedure, severity of surgery. Age will be included as a continuous variable, assuming a linear 
association with the outcome. Categorical variables with two or more categories will be included using 
indicator variables. Results will be presented as odds ratios with a 95% confidence interval.  
 
All analyses will be undertaken using STATA 15 (StataCorp, USA).  
 
Secondary outcomes 
The secondary outcome measures will be 30-day mortality and hospital length of stay. We will use 
univariate logistic regression and present crude 30-day mortality (dependent variable) rates for 
patients with or without post-operative infection (independent variable).  Secondary outcomes will 
be analysed using the same approach as the primary outcome. Analyses will also be repeated for each 
infection type. Forest plots comparing mortality for each infection type will be presented to show each 
OR with 95% CI. We will report rates of different treatments for post-operative infectious 
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complications by type of infection. We will test association between infection and hospital length of 
stay using a mixed effects linear regression model and present these in the supplementary material. 
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Figures and tables 
Figure 1. STROBE flow diagram of study population 
Total ISOS study cohort 
(n=44,814) 
Excluded: missing infection 
outcome (n=) 
 
Patients included into sub-study 
(n=) 
Reason for further exclusion (if 
applicable) (n=) 
 
Dataset analysed 
(n=) 
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Table 1. Baseline patient characteristics. 
All data presented as n (%) unless specified otherwise. ASA, American Society of Anesthesiologists physical status 
score; COPD, chronic obstructive pulmonary disease. 
 All patients 
Patients with 
infection 
Patients without 
infection 
n=44814 n= n= 
Age in years (mean SD)    
Age in years (median range)    
Male    
Smoker    
ASA score 
I    
II    
III    
IV    
Co-morbid disease 
Coronary artery disease    
Heart failure    
Diabetes mellitus    
Cirrhosis    
Metastatic cancer    
Stroke    
COPD / asthma    
Other    
Most recent result before surgery  
Haemoglobin g/L (median range)    
Leukocytes x109/L (median range)    
Sodium mmol/L (median  range)    
Creatinine µmol/L (median range)    
Anaesthetic technique 
General    
Spinal    
Epidural    
Sedation/Local    
Surgical procedure 
Orthopaedic    
Breast    
Obstetrics and gynaecology    
Urology and kidney    
Upper gastro-intestinal    
Lower gastro-intestinal    
Hepato-biliary    
Vascular    
Head and neck    
Plastics and cutaneous    
Cardiac    
Thoracic    
Other    
Severity of surgery    
Minor    
Intermediate    
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Major    
Other measures 
Laparoscopic surgery    
Cancer surgery    
Use of surgical checklist    
Critical care immediately after surgery    
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Table 2. Infection after surgery.  
Univariate (unadjusted) and multivariable (adjusted) logistic regression models for development of post-
operative infection. Data presented as odds ratios and 95% confidence intervals (CI). ASA, American Society of 
Anesthesiologists physical status score; COPD, chronic obstructive pulmonary disease. 
 Infection 
n (%) 
Unadjusted OR 
(95% CI) 
Adjusted OR 
(95% CI) p-value 
Age  --- --- --- 
Male     
Current smoker     
ASA score 
I  Reference --- --- 
II     
III     
IV     
Co-morbidity 
Coronary artery disease     
Heart failure     
Diabetes mellitus     
Cirrhosis     
Stroke     
COPD/Asthma     
Other     
Surgical procedure 
Orthopaedics     
Breast     
Obstetrics and gynaecology     
Urology & kidney     
Upper gastro-intestinal     
Lower gastro-intestinal     
Hepato-biliary     
Vascular     
Head and neck     
Plastics and cutaneous     
Cardiac     
Thoracic      
Other     
Severity of surgery 
Minor  Reference --- --- 
Intermediate     
Major     
Other measures 
Laparoscopic surgery     
Cancer surgery     
Use of surgical checklist     
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Table 3. Post-operative infections and mortality. 
Data presented as n (%). Some patients may have developed more than one complication, and consequently in some cases the denominator is the number complications 
whilst in the left most column the denominator is the number of patients. The cell at the bottom of the far right column represents the number of deaths divided by the 
number of patients with at least one complication. Univariate (unadjusted) and multivariable (adjusted) logistic regression models for development of post-operative 
infection for each type and total number of infections. Adjusted variables include patient characteristics and anaesthetic and surgical factors used in primary analyses. Data 
presented as odds ratios and 95% confidence intervals (CI). 
 n Severity of complications Mortality Unadjusted OR (95% CI) 
Adjusted OR 
(95% CI) p-value Mild Moderate Severe 
No infection  - - -  - - - 
Infection    
Superficial surgical site 1320 (2.9) 681/1320 (51.6) 
517/1320 
(39.2) 
122/1320 
(9.2) 
17/1320 
(1.3)    
Deep surgical site 566 (1.3) 120/566 (21.2) 
250/566 
(44.2) 
196/566 
(34.6) 28/566 (4.9)    
Body cavity 340 (0.8) 97/340 (28.5) 136/340 (40.0) 
107/340 
(31.5) 24/340 (7.0)    
Pneumonia 708 (1.6) 240/708 (33.9) 
325/708 
(45.9) 
143/708 
(20.2) 55/708 (7.8)    
Urinary tract 681 (1.5) 294/681 (43.2) 
333/681 
(48.9) 54/681 (7.9) 13/681 (1.9)    
Bloodstream 417 (0.9) 140/417 (33.6) 
162/417 
(38.8) 
115/417 
(27.6) 
48/417 
(11.5)    
Total 4032 1572/4032 (39.0) 
1723/4032 
(42.7) 
737/4032 
(18.3) 
104/4032 
(2.6)    
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Figure 2. Forest plots showing the odds ratios for 30-day mortality for different types of infection. (Example) 
 
 
Table 4. Effect of post-operative infection on hospital length of stay.  
Univariate (unadjusted) linear regression models for hospital length of stay in days. Data presented as mean 
(SD) with beta coefficients and 95% confidence intervals (CI). 
 Hospital length of stay 
n= 
Mean (SD) b coefficient (95% CI) p-value 
No infection  -  
Infection 
Superficial surgical site    
Deep surgical site    
Body cavity    
Pneumonia    
Urinary tract    
Bloodstream    
Total    
 
  
Surgical incision
Surgical abscess
UTI
URTI
Pneumonia
Peritonitis
Osteomyelitis
CNS
Other
Infection
3.02 (2.24, 4.08)
2.01 (0.89, 4.55)
2.39 (1.59, 3.59)
9.81 (4.67, 20.57)
12.05 (9.17, 15.85)
30.70 (19.48, 48.37)
5.23 (0.69, 39.68)
23.53 (9.41, 58.88)
8.85 (6.64, 11.80)
OR (95% CI)
  1.01 .05 10 25
30-day mortality OR (95% CI) 
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Supplementary Figure S2. Paper case record form (CRF) for International Surgical Outcomes Study. 
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